These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23325866)
1. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866 [TBL] [Abstract][Full Text] [Related]
2. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD). Wright E; Schofield PT; Seed P; Molokhia M PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825 [TBL] [Abstract][Full Text] [Related]
4. Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case-control studies using two primary-care databases. Vinogradova Y; Coupland C; Hippisley-Cox J Br J Cancer; 2013 Aug; 109(3):795-806. PubMed ID: 23868009 [TBL] [Abstract][Full Text] [Related]
5. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea. Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies. Oh YH; Yoon C; Park SM World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320 [TBL] [Abstract][Full Text] [Related]
7. Exposure to weak opioids and risk of gastrointestinal tract cancers: A series of nested case-control studies. Houston MG; McMenamin Ú; Johnston B; McDowell RD; Hughes CM; Murchie P; Cardwell CR Br J Clin Pharmacol; 2023 Sep; 89(9):2757-2766. PubMed ID: 37117154 [TBL] [Abstract][Full Text] [Related]
8. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ; 2015 May; 350():h2135. PubMed ID: 26013557 [TBL] [Abstract][Full Text] [Related]
9. Exposure to oral bisphosphonates and risk of esophageal cancer. Cardwell CR; Abnet CC; Cantwell MM; Murray LJ JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457 [TBL] [Abstract][Full Text] [Related]
10. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463 [TBL] [Abstract][Full Text] [Related]
11. The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data. Busby J; Murchie P; Murray L; Iversen L; Lee AJ; Spence A; Watson MC; Cardwell CR Int J Cancer; 2017 Apr; 140(8):1828-1835. PubMed ID: 28120338 [TBL] [Abstract][Full Text] [Related]
12. Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ Open; 2012; 2(1):e000548. PubMed ID: 22240651 [TBL] [Abstract][Full Text] [Related]
13. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. Vinogradova Y; Coupland C; Hippisley-Cox J BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755 [TBL] [Abstract][Full Text] [Related]
14. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study. Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M; Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594 [TBL] [Abstract][Full Text] [Related]
15. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models. Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308 [TBL] [Abstract][Full Text] [Related]
16. Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases. Vinogradova Y; Dening T; Hippisley-Cox J; Taylor L; Moore M; Coupland C BMJ; 2021 Sep; 374():n2182. PubMed ID: 34588168 [TBL] [Abstract][Full Text] [Related]
17. Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network. García Rodríguez LA; Soriano-Gabarró M; Vora P; Cea Soriano L Int J Cancer; 2020 Nov; 147(9):2394-2404. PubMed ID: 32329063 [TBL] [Abstract][Full Text] [Related]
18. Exposure to oral bisphosphonates and risk of gastrointestinal cancer. Choi D; Choi S; Chang J; Park SM Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451 [TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis. Wright E; Schofield PT; Molokhia M BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118 [TBL] [Abstract][Full Text] [Related]
20. Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study. Asghar ZB; Godoy Caballero A; Pathirannehelage S; Williams J; McKay S; Grassby P; de Lusignan S; Niroshan Siriwardena A Osteoporos Int; 2019 Sep; 30(9):1845-1854. PubMed ID: 31214750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]